Abbott Laboratories Just Got Interesting: Dividend Yield Near 3% Signals Opportunity

Abbott Laboratories (ABT) offers a 2.5% dividend yield, over 50 years of increases, and trades at a forward P/E below its 5-year average. Recent post-earnings sell-off, driven by lowered EPS guidance and Nutrition segment weakness, presents a compelling long-term buying opportunity. ABT's balance sheet remains robust with $8.5B in cash, manageable debt, and projected 40.5% free cash flow growth by 2028.